Evaluation of a biosensor immunoassay for simultaneous characterization of isotype and binding region of human anti-tocilizumab antibodies with control by surrogate standards.
暂无分享,去创建一个
K. Stubenrauch | Uwe Wessels | Kay Stubenrauch | J. Schleypen | Uwe Wessels | Rudolf Vogel | Julia Schleypen | Rudolf Vogel
[1] R. Jefferis,et al. Multiple interactions of IgG with its core oligosaccharide can modulate recognition by complement and human Fc gamma receptor I and influence the synthesis of its oligosaccharide chains. , 1996, Journal of immunology.
[2] T. Kishimoto,et al. The recombinant humanized anti-IL-6 receptor antibody tocilizumab, an innovative drug for the treatment of rheumatoid arthritis , 2008, Expert opinion on biological therapy.
[3] R Thorpe,et al. Strategies for detection, measurement and characterization of unwanted antibodies induced by therapeutic biologicals. , 2003, Journal of immunological methods.
[4] Meina Liang,et al. Detection of high- and low-affinity antibodies against a human monoclonal antibody using various technology platforms. , 2007, Assay and drug development technologies.
[5] A. Mire-Sluis,et al. Immune responses to therapeutic proteins in humans--clinical significance, assessment and prediction. , 2002, Current pharmaceutical biotechnology.
[6] Steven J. Swanson,et al. Evaluation of Methods to Detect and Characterize Antibodies against Recombinant Human Erythropoietin , 2004, Nephron Clinical Practice.
[7] A. Epstein,et al. Immunogenicity of Iodine 131 chimeric tumor necrosis therapy monoclonal antibody in advanced lung cancer patients , 2008, Cancer Immunology, Immunotherapy.
[8] S. Morrison,et al. Monoclonal IgM rheumatoid factors bind IgG at a discontinuous epitope comprised of amino acid loops from heavy-chain constant-region domains 2 and 3. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[9] F. Legay,et al. Improvement of drug tolerance in immunogenicity testing by acid treatment on Biacore. , 2008, Journal of immunological methods.
[10] N. Kemeny,et al. Phase I study of anticolon cancer humanized antibody A33. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[11] G. Himmler,et al. Qualification and application of a surface plasmon resonance-based assay for monitoring potential HAHA responses induced after passive administration of a humanized anti Lewis-Y antibody. , 2006, Journal of pharmaceutical and biomedical analysis.
[12] George Scott,et al. Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products. , 2004, Journal of immunological methods.
[13] Arunan Kaliyaperumal,et al. Comparing ELISA and Surface Plasmon Resonance for Assessing Clinical Immunogenicity of Panitumumab , 2007, The Journal of Immunology.
[14] Janice M. Reichert,et al. Development trends for monoclonal antibody cancer therapeutics , 2007, Nature Reviews Drug Discovery.